Urinalysis Market Size By Product (Consumables {Dipsticks, Reagents, Disposables}, Instruments {Biochemical Urine Analyzer, Automated Urine Sediment Analyzer}), By Application (Urinary Tract Infections [UTI], Kidney Disease, Pregnancy, Diabetes), By End-U

Urinalysis Market Size By Product (Consumables {Dipsticks, Reagents, Disposables}, Instruments {Biochemical Urine Analyzer, Automated Urine Sediment Analyzer}), By Application (Urinary Tract Infections [UTI], Kidney Disease, Pregnancy, Diabetes), By End-Use (Clinical Laboratories, Hospitals, Home Healthcare), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028

The urinalysis market is anticipated to grow immensely by 2028 owing to rising incidences of chronic diseases across the globe. In addition, growing emphasis on early diagnosis as well as an increasing number of pregnancies, especially in developed countries, are likely to further foster industry growth through the forecast period.

Recently, research activities are increasingly focusing on developing user-friendly products that have easier accessibility, which has enhanced overall market dynamics. To that effect, a March 2022 study published in Sensors and Actuators B: Chemical devised a cost-efficiently made lab-in-a-Cup (LiC) hybrid urinalyzer that supports limited diffusion of urine, resulting in reproducible and sample volume urinalysis wired with smartphone image recognition algorithm for daily healthcare purposes. In addition, government initiatives focused on promoting kidney health by creating a better healthcare system and awareness camps have aided business growth.

The urinalysis market has been categorized based on product, end-use, application, and region. The product segment has been divided into consumables and instruments. Under consumables, the market has been further classified into dipsticks, reagents, and disposables.

The dipsticks segment generated over USD 750 million in revenue in 2021 and is projected to exhibit steady growth over 2022-2028. Factors like quick diagnosis with the use of dipstick urinalysis, ease-of-use & accessibility, high product availability, and benefits of use in home testing would aid in segmental growth.

In terms of application, the urinalysis market has been classified into kidney diseases, urinary tract infections (UTI), diabetes, pregnancy, and others. In 2021, the kidney diseases segment held more than 22% market share and is contemplated to witness notable growth in revenue in the upcoming years. High prevalence rate, increasing risk of severe complications, quick illness diagnosis with urinalysis, and growing awareness about early diagnosis of chronic kidney diseases (CKDs) in developed countries are set to fuel segmental demand.

With respect to end-use, the urinalysis market has been segregated into clinical laboratories, hospitals, home healthcare, and others. The home healthcare segment is slated to grow at a CAGR of approximately 5.0% from 2022 to 2028. Mounting number of product launches dedicated to home testing, increased preference for home services among the elderly population, and reduced diagnosis time are some factors that are primed to contribute to the growth of the segment.

In the regional landscape, the Latin America urinalysis market is estimated to grow at a CAGR of around 4.7% between 2022 and 2028. Growing network of diagnostic facilities in developing countries, surging focus of industry players on services expansion, and government initiatives to broaden accessibility are foreseen to promote regional market growth.